EcoR1 Capital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001587114

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q1 2024 · 57 positions · Total reported value $3.82B · Top-10 concentration 63.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.5% · 9 new · 4 cut · 6 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -3.0% · vs SPY -5.1% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.9% · vs SPY -1.2% · Latest Value $2.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, EcoR1 Capital, LLC disclosed 57 equity positions with a combined reported value of $3.82B. The filing implies a focused portfolio: its ten largest positions account for 63.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were APLS ($667.59M), PRTA ($286.94M), ARVN ($277.67M). By sector, the heaviest allocations are Health Care 62.2%, Materials 1.1%. Versus the prior quarter, allocation shifted toward Health Care (+3.9pp), Materials (+1.1pp) and away from Other (-5.0pp).

Versus the prior quarter, EcoR1 Capital, LLC opened 9 new positions, trimmed 4 and fully exited 6, a turnover rate of 47.5% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q1 2024 were CRSP ($94.69M), ADAPY ($43.30M), CLDX ($27.28M).

Of the 6 positions fully exited versus the prior quarter, the largest were MRTX ($434.57M), ARGX ($114.51M), GRPH ($22.37M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • CRSP CRISPR THERAPEUTICS AG · $94.69M
  • ADAPY ADAPTIMMUNE THERAPEUTICS PLC · $43.30M
  • CLDX CELLDEX THERAPEUTICS INC NEW · $27.28M
  • LENZ LENZ THERAPEUTICS INC · $27.24M
  • NKTX NKARTA INC · $21.62M
  • PCVX VAXCYTE INC · $20.49M
  • MDGL MADRIGAL PHARMACEUTICALS INC · $20.03M
  • RNAM AVIDITY BI · $19.33M

Fully Exited (vs previous quarter)

  • MRTX MIRATI THERAPEUTICS INC · prev qtr: $434.57M
  • ARGX ARGENX SE · prev qtr: $114.51M
  • GRPH GRAPHITE BIO INC · prev qtr: $22.37M
  • SYRE SPYRE THERAPEUTICS INC · prev qtr: $19.09M
  • RVMD REVOLUTION MEDICINES INC · prev qtr: $3.80M
  • NGM NGM BIOPHARMACEUTICALS INC · prev qtr: $2.05M
  • ALLK ALLAKOS INC · prev qtr: $2.04M
  • TYRA TYRA BIOSCIENCES INC · prev qtr: $1.90M

Insider Transactions (Form 4)

Latest EcoR1 Capital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-07 Buy Atara Biotherapeutics, Inc. 507,407 $9.35 SEC filing
2026-04-20 Sell First Tracks Biotherapeutics, Inc. 4,705,575 $13.81 SEC filing

All insider transactions →

Fund Profile

EcoR1 Capital, LLC, based in San Francisco, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 31 positions worth $1.95B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-100470 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $3.42B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds

Portfolio Structure

  • 31 positions · $1.95B reported value (Q2 2026)
  • Top 10 holdings = 87.7% of reported value
  • Largest position: ZYME (ZYMEWORKS INC) at 30.8%
  • Average position size: $62.85M

Sector Tilt

  • Health Care 97.3%
  • Financials 0.1%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 9 new, 2 added, 5 reduced, 7 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 62.2%
Materials 1.1%
Other 36.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 11.36M $667.59M 17.47%
17.47%
Add
2 11.58M $286.94M 7.51%
7.51%
Hold
3 6.73M $277.67M 7.27%
7.27%
Hold
4 1.92M $248.54M 6.50%
6.50%
Add
5 4.16M $194.51M 5.09%
5.09%
Add
6 5.76M $185.35M 4.85%
4.85%
Hold
7 7.52M $169.37M 4.43%
4.43%
Hold
8 13.44M $141.36M 3.70%
3.70%
Hold
9 1.01M $122.10M 3.19%
3.19%
Hold
10 5.33M $117.96M 3.09%
3.09%
Add
11 5.99M $110.78M 2.90%
2.90%
Hold
12 13.33M $105.85M 2.77%
2.77%
Hold
13 3.88M $95.74M 2.50%
2.50%
Hold
14 1.39M $94.69M 2.48%
2.48%
New
15 19.36M $86.75M 2.27%
2.27%
Hold
16 2.38M $83.93M 2.20%
2.20%
Add
17 19.21M $69.92M 1.83%
1.83%
Hold
18 1.27M $64.71M 1.69%
1.69%
Hold
19 5.62M $63.49M 1.66%
1.66%
Hold
20 3.42M $47.00M 1.23%
1.23%
Hold
21 27.40M $43.30M 1.13%
1.13%
New
22 5.00M $39.70M 1.04%
1.04%
Hold
23 3.92M $36.47M 0.95%
0.95%
Add
24 3.18M $30.04M 0.79%
0.79%
Hold
25 2.07M $28.48M 0.74%
0.74%
Hold
26 650.00K $27.28M 0.71%
0.71%
New
27 2.00M $27.27M 0.71%
0.71%
Add
28 1.22M $27.24M 0.71%
0.71%
New
29 6.15M $24.83M 0.65%
0.65%
Reduce
30 4.06M $24.42M 0.64%
0.64%
Hold
31 1.25M $22.81M 0.60%
0.60%
Reduce
32 2.00M $21.62M 0.57%
0.57%
New
33 900.00K $20.80M 0.54%
0.54%
Hold
34 300.00K $20.49M 0.54%
0.54%
New
35 75.00K $20.03M 0.52%
0.52%
New
36 757.58K $19.33M 0.51%
0.51%
New
37 6.12M $18.66M 0.49%
0.49%
Hold
38 1.25M $16.60M 0.43%
0.43%
Hold
39 700.00K $14.93M 0.39%
0.39%
Reduce
40 187.50K $12.41M 0.33%
0.33%
New
41 427.04K $12.12M 0.32%
0.32%
New
42 450.00K $11.18M 0.29%
0.29%
New
43 9.20M $10.85M 0.28%
0.28%
Hold
44 11.29M $8.53M 0.22%
0.22%
New
45 2.05M $8.33M 0.22%
0.22%
Hold
46 10.17M $7.06M 0.18%
0.18%
Add
47 2.88M $6.60M 0.17%
0.17%
Reduce
48 6.39M $6.26M 0.16%
0.16%
Hold
49 500.00K $4.96M 0.13%
0.13%
New
50 700.00K $4.90M 0.13%
0.13%
New

FAQ

What did EcoR1 Capital, LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, EcoR1 Capital, LLC reported 57 equity positions worth $3.82B in aggregate; its largest disclosed positions were APLS ($667.59M), PRTA ($286.94M), ARVN ($277.67M).

How large is EcoR1 Capital, LLC's portfolio?

EcoR1 Capital, LLC reported $3.82B of long equity holdings across 57 positions as of 2024-Q1. Top-10 holdings account for 63.1% of reported value.

What is EcoR1 Capital, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ecor1-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →